--- The Clinical Frontier The strongest human evidence now supports: Metformin (metabolic reprogramming) NAD boosters (mitochondrial repair) MSC infusions & TPE (cellular rejuvenation) GLP-1 agonists (metabolic efficiency) The future lies in combination strategies integrating metabolism, cellular repair, and mitochondrial support for multimodal rejuvenation
Non-alcoholic fatty liver disease (NAFLD) can originate from unassuming steatosis and if it is not treated it may develop into smooth hepato-cellular and cirrhosis nonalcoholic steatohepatitis (NASH) (Hillenbrand et al., 2015
2.11 Determination of SOD enzyme activity At 1, 3, 6, 9, and 12 days after virus infection, infected leaves were collected to measure the activity of SOD disease-resistance and defense enzymes
usually mild) Fishy body odor (due to trimethylamine production) Headache (occasional) Increased appetite (some patients) When to Contact Healthcare Provider: Severe GI symptoms Signs of allergic reaction (rash, swelling) Increased seizure frequency (if history of epilepsy) Unusual bleeding or bruising (if on warfarin) Symptoms of hypothyroidism (fatigue, weight gain, cold intolerance) Drug and Supplement Interactions: Warfarin: May increase anticoagulant effect